BRCM
Bright Rock Capital Management’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.75M | Hold |
40,000
| – | – | 1.77% | 21 |
|
2025
Q1 | $8.96M | Buy |
40,000
+4,000
| +11% | +$896K | 1.89% | 19 |
|
2024
Q4 | $11.8M | Sell |
36,000
-11,000
| -23% | -$3.6M | 2.52% | 9 |
|
2024
Q3 | $14.1M | Buy |
47,000
+21,000
| +81% | +$6.3M | 2.84% | 6 |
|
2024
Q2 | $8.56M | Hold |
26,000
| – | – | 1.81% | 20 |
|
2024
Q1 | $10.3M | Hold |
26,000
| – | – | 2.13% | 15 |
|
2023
Q4 | $9.16M | Buy |
26,000
+10,000
| +63% | +$3.52M | 2.07% | 19 |
|
2023
Q3 | $6M | Hold |
16,000
| – | – | 1.47% | 27 |
|
2023
Q2 | $6.12M | Buy |
16,000
+11,000
| +220% | +$4.21M | 1.43% | 28 |
|
2023
Q1 | $1.73M | Hold |
5,000
| – | – | 0.43% | 64 |
|
2022
Q4 | $1.18M | Sell |
5,000
-20,000
| -80% | -$4.71M | 0.31% | 74 |
|
2022
Q3 | $6.15M | Hold |
25,000
| – | – | 1.73% | 20 |
|
2022
Q2 | $7.56M | Buy |
25,000
+20,000
| +400% | +$6.05M | 2.04% | 14 |
|
2022
Q1 | $2.05M | Hold |
5,000
| – | – | 0.48% | 62 |
|
2021
Q4 | $2.35M | Hold |
5,000
| – | – | 0.53% | 57 |
|
2021
Q3 | $2.12M | Hold |
5,000
| – | – | 0.53% | 57 |
|
2021
Q2 | $1.8M | Buy |
+5,000
| New | +$1.8M | 0.43% | 65 |
|